ArticleDeutsches Arzteblatt international2025
Arterial Hypertension: The Incidence of Diagnosed Hypertension, 24-Hour Blood Pressure Measurement and Pharmacotherapy. An Analysis of Routine Health Insurance Data.
Article in Deutsches Arzteblatt international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Incidence of arterial hypertension in Germany 2009-2018 based on prevalence data from 70 million patients from the statutory health insurance.BMC cardiovascular disorders · 2026Article
- [Preventive fields in endocrinology/diabetology-The big five].Innere Medizin (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArterial hypertension is a major risk factor for morbidity and mortality in Germany. No current data are available on trends in the incidence of hypertension.
methodsThe incidence of diagnosed hypertension (ICD codes I10.- to I15.-) and the utilization of 24-hour ambulatory blood pressure measurement (ABPM) and antihypertensive drugs were determined in an analysis of anonymized routine data on 4.8 million persons covered by the statutory health insurance system in Germany. The data were linked to the German Index of Socioeconomic Deprivation on the basis of the subjects' place of residence and evaluated with stratification by age group, sex, and regional socioeconomic deprivation.
resultsIn 2017, the age-standardized incidence of diagnosed hypertension was 20.6 per 1000 persons. It fell in the first year of the COVID-19 pandemic, rose again in 2021, and reached 20.7 per 1000 in 2023. In 2023, the incidence of diagnosed hypertension was markedly higher in regions with high socioeconomic deprivation than in low-deprivation regions (24.6 versus 17.9 per 1000). Among persons who received a diagnosis of hypertension in 2023, 82.3% received medication and 30.1% underwent ABPM within one year of their diagnosis.
conclusionThe high incidence of diagnosed hypertension underscores the need for a well-developed preventive strategy. The downward trend that was observed over the past decade is no longer evident. This matter should be investigated further with a nationwide investigative survey that also takes undiagnosed hypertension into account.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.